Valsalva haemorrhagic retinopathy in a pregnant woman

Callender, Donell; Beirouty, Zeidoon A.Y.; Saba, Shanmugam N.

doi:10.1038/eye.1995.203

Cited by 26 publications

(15 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3 Reported causes of a Valsalva maneuver include straining and physical activities, most commonly during coughing, weight lifting, vomiting, aerobic exercise, sexual activity, endstage labour, dental procedures, colonoscopy procedures, constipation, blowing musical instruments, and compressive injuries. [3][4][5][6][7][8][9][10][11] Nd:YAG laser treatment is a non-invasive method, which enables the drainage of the extensive premacular subhyaloid haemorrhage into the vitreous, facilitates absorption of blood cells and improves the vision within days by clearance of the obstructed premacular area.…”

Section: Introductionmentioning

confidence: 99%

Long-term results of Nd:YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy

Durukan

Kerimoğlu

Erdurman

et al. 2006

Eye

View full text Add to dashboard Cite

Aims Valsalva retinopathy produces sudden visual loss, which may be prolonged if untreated. Nd:YAG laser enables rapid diffusion of premacular subhyaloid haemorrhage. This study was performed to assess the long-term results and safety of Nd:YAG laser treatment in cases with Valsalva retinopathy. Methods Sixteen patients had Nd:YAG laser treatment to drain premacular haemorrhage. The follow-up period was 24 months. Results All eyes had marked clearing of haemorrhage and immediate improvement of vision following laser treatment. In 14 eyes visual acuity improved to 20/20 level at the end of the first week and the remaining two patients achieved 20/20 level within 1 month. No patient had evidence of retinal or choroidal damage. Conclusion Nd:YAG laser treatment for Valsalva retinopathy is an effective, noninvasive, and safe procedure for patients with a premacular subhyaloid haemorrhage larger than 3 disc diameter and no longer than 3 weeks of duration.

show abstract

Section: Introductionmentioning

confidence: 99%

Long-term results of Nd:YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy

Durukan

Kerimoğlu

Erdurman

et al. 2006

Eye

View full text Add to dashboard Cite

show abstract

“…Valsalva maculopathy has been reported following aerobic exercise,5 vigorous sexual activity,6 inflating balloons,7 prostate8 and dental surgery,9 episodes of constipation, vomiting and lifting in pregnant women,10 , 11 and in acute Leber’s optic neuropathy 12…”

Section: Discussionmentioning

confidence: 99%

Maculopathy: a rare association of the Valsalva manoeuvre (Valsalva maculopathy)

Sheikh

Untoo²,

Lone³

et al. 2010

Case Reports

View full text Add to dashboard Cite

A 22-year-old man complained of sudden, painless loss of vision (vague scotoma in central vision) in his right eye. The patient became symptomatic following a session of weight training at a gymnasium the previous day. There was no history trauma. Medical, ocular and familial history were unremarkable. The inferior and temporal aspect of the haemorrhage was darker due to gravitation, but the rest of the fundus was normal. The appearance of the right fundus, combined with an associated unequivocal history of physical exertion, was consistent with a diagnosis of Valsalva maculopathy (holding breath while bench pressing). Systemic examination and all relevant blood tests were normal. Fluorescein angiography (FFA) was done which confirmed the diagnosis. The patient recovered a vision of 6/6 in his right eye after 2 months. FFA was again done, which showed no sequelae of the problem.

show abstract

“…[131][132][133] Decreased venous return with associated increased intracranial venous pressure is believed to precipitate these hemorrhages. Loss of vision may occur after heavy lifting, straining at stool, coughing, or vomiting, although in some instances no initiating event is identified.…”

Section: Valsalva Retinopathymentioning

confidence: 98%